| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA620437 | F | Inhibition of human ovarian carcinoma (A90) FGF-R overexpressing cell proliferation | Homo sapiens | 8 | ALA1133506 | cell-based format | Scientific Literature | |
| 2. | ALA695488 | F | Cytotoxic activity against human ovarian cancer cell line | Homo sapiens | 7 | ALA1128647 | cell-based format | Scientific Literature | |
| 3. | ALA695489 | F | Clonogenic survival activity against human ovarian cancer cells (2008, C13*) cells; 0.01-10 range | Homo sapiens | 2 | ALA1134912 | cell-based format | Scientific Literature | |
| 4. | ALA695490 | F | Tested for anticancer activity against human ovarian cancer | Homo sapiens | 3 | ALA1134421 | cell-based format | Scientific Literature | |
| 5. | ALA695491 | F | Tested for anticancer activity against human ovarian cancer; NT means Not tested | Homo sapiens | 3 | ALA1134421 | cell-based format | Scientific Literature | |
| 6. | ALA695492 | F | Antitumor potency against human ovarian cancer cells in clonogenic assay | Homo sapiens | 8 | ALA1124782 | cell-based format | Scientific Literature | |
| 7. | ALA695494 | F | Compound was evaluated for the growth inhibition of cell cultures derived from human ovarian cancer tumors | Homo sapiens | 6 | ALA1133028 | cell-based format | Scientific Literature | |
| 8. | ALA695495 | F | Cytotoxicity in non-NTR-expressing human ovarian carcinoma cell line (SKOV). | Homo sapiens | 17 | ALA1145792 | cell-based format | Scientific Literature | |
| 9. | ALA695496 | F | Ratio of cytotoxicity in a non-NTR-expressing SKOV compared to that in NTR-expressing SKOV. | Homo sapiens | 17 | ALA1145792 | cell-based format | Scientific Literature | |
| 10. | ALA816268 | F | In vitro median growth inhibitory concentration against ovarian cancer cell lines | Homo sapiens | 9 | ALA1133460 | cell-based format | Scientific Literature | |
| 11. | ALA878035 | F | In vitro growth inhibitory concentration against ovarian cancer cell lines | Homo sapiens | 11 | ALA1133460 | cell-based format | Scientific Literature | |
| 12. | ALA4738937 | F | Growth inhibition of human Ovarian cancer cell line incubated for 48 hrs by sulforhodamine B assay | Homo sapiens | 3 | ALA4732237 | cell-based format | Scientific Literature | |
| 13. | ALA5096394 | F | Cytotoxicity against human ovarian cancer cell line assessed as reduction in cell viability by MTT assay relative to control | Homo sapiens | 2 | ALA5096145 | cell-based format | Scientific Literature | |
| 14. | ALA5110983 | F | Anticancer activity against patient-derived human Ovarian tumor cells assessed as tumor growth inhibition incubated for 72 hrs by FMCA assay | Homo sapiens | 2 | ALA5108035 | cell-based format | Scientific Literature | |
| 15. | ALA5121744 | F | Antiproliferative activity against human ovarian cancer cells after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay | Homo sapiens | 1 | ALA5120768 | cell-based format | Scientific Literature | |
| 16. | ALA5245365 | F | Antiproliferative activity against human Ovarian cancer cell line | Homo sapiens | 2 | ALA5244230 | cell-based format | Scientific Literature | |
| 17. | ALA5245408 | F | Potency index, ratio of artemisinin IC50 to test compound IC50 for antiproliferative activity against human Ovarian cancer cell line assessed as inhibition of cell growth | Homo sapiens | 1 | ALA5244230 | cell-based format | Scientific Literature | |
| 18. | ALA5264914 | F | Antiproliferative activity against human ovarian cancer cells assessed as cell growth inhibition at 10 uM by SRB assay relative to control | Homo sapiens | 4 | ALA5260845 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!